Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 30.02 Million ILS | 1483.76% |
| 2022 | 1.89 Million ILS | 104.58% |
| 2021 | -41.36 Million ILS | 31.54% |
| 2020 | -60.42 Million ILS | -242.41% |
| 2019 | -17.64 Million ILS | -290.64% |
| 2018 | 9.25 Million ILS | 110.02% |
| 2017 | -92.37 Million ILS | -5.78% |
| 2016 | -87.32 Million ILS | 43.69% |
| 2015 | -155.09 Million ILS | -47.69% |
| 2014 | -105.01 Million ILS | -402.97% |
| 2013 | 34.66 Million ILS | 240.42% |
| 2012 | -24.68 Million ILS | 22.13% |
| 2011 | -31.69 Million ILS | 59.19% |
| 2010 | -77.68 Million ILS | 58.17% |
| 2009 | -185.72 Million ILS | 13.58% |
| 2008 | -214.89 Million ILS | 12.5% |
| 2007 | -245.6 Million ILS | -589.04% |
| 2006 | -35.64 Million ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 29.55 Million ILS | 870.92% |
| 2023 FY | 30.02 Million ILS | 1483.76% |
| 2023 Q2 | -3.83 Million ILS | -114.35% |
| 2023 Q4 | 30.02 Million ILS | 1.59% |
| 2023 Q1 | 26.71 Million ILS | 1309.12% |
| 2022 Q4 | 1.89 Million ILS | 769.96% |
| 2022 Q1 | -61.69 Million ILS | -49.14% |
| 2022 FY | 1.89 Million ILS | 104.58% |
| 2022 Q2 | -30.93 Million ILS | 49.86% |
| 2022 Q3 | -283 Thousand ILS | 99.09% |
| 2021 FY | -41.36 Million ILS | 31.54% |
| 2021 Q2 | -69.67 Million ILS | 45.5% |
| 2021 Q3 | -74.39 Million ILS | -6.79% |
| 2021 Q4 | -41.36 Million ILS | 44.4% |
| 2021 Q1 | -127.82 Million ILS | -111.56% |
| 2020 Q4 | -60.42 Million ILS | -29.52% |
| 2020 FY | -60.42 Million ILS | -242.41% |
| 2020 Q1 | -32.1 Million ILS | -81.92% |
| 2020 Q2 | -51.97 Million ILS | -61.92% |
| 2020 Q3 | -46.64 Million ILS | 10.25% |
| 2019 Q3 | -30.26 Million ILS | 67.56% |
| 2019 FY | -17.64 Million ILS | -290.64% |
| 2019 Q4 | -17.64 Million ILS | 41.7% |
| 2019 Q1 | -34.67 Million ILS | -474.62% |
| 2019 Q2 | -93.3 Million ILS | -169.08% |
| 2018 FY | 9.25 Million ILS | 110.02% |
| 2018 Q4 | 9.25 Million ILS | -77.83% |
| 2018 Q3 | 41.75 Million ILS | 234.83% |
| 2018 Q2 | -30.96 Million ILS | -321.79% |
| 2018 Q1 | 13.96 Million ILS | 115.11% |
| 2017 Q1 | 21.01 Million ILS | 124.06% |
| 2017 Q4 | -92.37 Million ILS | -50.6% |
| 2017 Q3 | -61.33 Million ILS | -323.97% |
| 2017 FY | -92.37 Million ILS | -5.78% |
| 2017 Q2 | 27.38 Million ILS | 30.32% |
| 2016 Q3 | 22 Million ILS | 266.43% |
| 2016 FY | -87.32 Million ILS | 43.69% |
| 2016 Q2 | 6 Million ILS | 332.64% |
| 2016 Q4 | -87.32 Million ILS | -496.86% |
| 2016 Q1 | 1.38 Million ILS | 100.89% |
| 2015 Q1 | -87.71 Million ILS | 16.47% |
| 2015 FY | -155.09 Million ILS | -47.69% |
| 2015 Q4 | -155.09 Million ILS | -48.64% |
| 2015 Q3 | -104.33 Million ILS | -164.97% |
| 2015 Q2 | -39.37 Million ILS | 55.11% |
| 2014 Q2 | -110.17 Million ILS | 53.94% |
| 2014 FY | -105.01 Million ILS | -402.97% |
| 2014 Q1 | -239.17 Million ILS | -790.01% |
| 2014 Q4 | -105.01 Million ILS | -98.56% |
| 2014 Q3 | -52.88 Million ILS | 51.99% |
| 2013 Q1 | -7.66 Million ILS | 68.94% |
| 2013 Q2 | -106.22 Million ILS | -1285.7% |
| 2013 Q3 | -10.93 Million ILS | 89.7% |
| 2013 FY | 34.66 Million ILS | 240.42% |
| 2013 Q4 | 34.66 Million ILS | 416.87% |
| 2012 Q4 | -24.68 Million ILS | 0.0% |
| 2012 FY | -24.68 Million ILS | 22.13% |
| 2011 FY | -31.69 Million ILS | 59.19% |
| 2010 FY | -77.68 Million ILS | 58.17% |
| 2009 FY | -185.72 Million ILS | 13.58% |
| 2008 FY | -214.89 Million ILS | 12.5% |
| 2007 FY | -245.6 Million ILS | -589.04% |
| 2006 FY | -35.64 Million ILS | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Matricelf Ltd | -835 Thousand ILA | 3696.168% |